Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus

被引:1
|
作者
Kass, E
Schlom, J
Thompson, J
Guadagni, F
Graziano, P
Greiner, JW
机构
[1] NCI, Tumor Immunol & Biol Lab, NIH, Bethesda, MD 20892 USA
[2] Regina Elena Canc Inst, I-00161 Rome, Italy
[3] Univ Freiburg, D-79104 Freiburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human carcinoembryonic antigen (CEA is a well-characterized oncofetal glycoprotein whose overexpression by human carcinomas has been a target for cancer immunotherapy, Transgenic mice that express CEA as a self-antigen with a tissue distribution similar to that of humans have been developed. This study investigates: (a) the responsiveness of the CEA transgenic (CEA.Tg) mice to endogenous CEA or CEA administered as a whole protein in adjuvant; and (b) whether the presentation of CEA as a recombinant vaccinia virus could generate CEA-specific host immunity. By and large, the CEA.Tg mice were unresponsive to CEA, as shown by the lack of detectable CEA-specific serum antibodies and the inability to prime an in vitro splenic T-cell response to CEA. Furthermore, the administration of whole CEA protein in adjuvant to CEA.Tg mice failed to elicit either anti-CEA Ige titers or CEA-specific T-cell responses. Only weak anti-CEA IgM antibody titers a ere round in those mice. In contrast, CEA.Tg mice immunized with recombinant vaccinia virus expressing CEA generated relatively strong anti-CEA Ige antibody titers and demonstrated evidence of immunoglobulin class switching, These mice also developed T(H)1-type CEA-specific CD4(+) responses and CEA peptide-specific cytotoxicity. The ability to generate CEA-specific host immunity correlated with protection of the CEA,Tg mice against a challenge with CEA-expressing tumor cells, Protection against tumor growth was accomplished with no apparent immune response directed at CEA-positive normal tissues. The results demonstrate the ability to generate an effective antitumor immune response to a tumor self-antigen by immunization with a recombinant vaccinia virus. CEA,Tg mice should be an excellent experimental model to study the effects of more aggressive immunization schemes directed at established tumors with the possible development of accompanying autoimmune responses involving normal tissues.
引用
收藏
页码:676 / 683
页数:8
相关论文
共 50 条
  • [1] Breaking of tolerance and induction of protective host immunity in 45 CEA transgenic mice (CEA.Tg) immunized with a recombinant vaccinia-CEA virus (rV-CEA).
    Kass, E
    Abrams, S
    Schlom, J
    Greiner, JW
    FASEB JOURNAL, 1999, 13 (04): : A645 - A645
  • [2] Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine
    Conry, RM
    Allen, KO
    Lee, SW
    Moore, SE
    Shaw, DR
    LoBuglio, AF
    CLINICAL CANCER RESEARCH, 2000, 6 (01) : 34 - 41
  • [3] A RECOMBINANT VACCINIA VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN (CEA)
    KAUFMAN, H
    SCHLOM, J
    KANTOR, J
    INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (06) : 900 - 907
  • [4] Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice
    Xiang, R
    Silletti, S
    Lode, HN
    Dolman, CS
    Ruehlmann, JM
    Niethammer, AG
    Pertl, U
    Gillies, SD
    Primus, FJ
    Reisfeld, RA
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 856S - 864S
  • [5] Recombinant vaccinia virus (rV) expression of a CTL epitope from carcinoembryonic antigen (CEA).
    Guptill, VA
    Zaremba, S
    Schlom, J
    Kantor, JA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 186 - 186
  • [6] ENHANCED IMMUNE-RESPONSES AND ANTITUMOR-ACTIVITY BY BACULOVIRUS RECOMBINANT CARCINOEMBRYONIC ANTIGEN (CEA) IN MICE PRIMED WITH THE RECOMBINANT VACCINIA CEA
    BEI, R
    KANTOR, J
    KASHMIRI, SVS
    ABRAMS, S
    SCHLOM, J
    JOURNAL OF IMMUNOTHERAPY, 1994, 16 (04) : 275 - 282
  • [7] CELLULAR-IMMUNITY AND CARCINOEMBRYONIC ANTIGEN (CEA)
    HEIDEL, G
    GROSSMAN, H
    MUELLER, M
    IRMSCHER, J
    KOTZSCH, M
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1981, 2 (03): : 208 - 208
  • [8] DEVELOPMENT OF A RECOMBINANT VACCINIA-CARCINOEMBRYONIC ANTIGEN (CEA) VACCINE FOR IMMUNOTHERAPY OF HUMAN CARCINOMA
    SCHLOM, J
    KANTOR, J
    ABRAMS, S
    IRVINE, K
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 671 - 671
  • [9] Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice
    Luo, YP
    O'Hagan, D
    Zhou, H
    Singh, M
    Ulmer, J
    Reisfeld, RA
    Primus, FJ
    Xiang, R
    VACCINE, 2003, 21 (17-18) : 1938 - 1947
  • [10] Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice
    Saha, A
    Chatterjee, SK
    Foon, KA
    Primus, FJ
    Sreedharan, S
    Mohanty, K
    Bhattacharya-Chatterjee, M
    CANCER RESEARCH, 2004, 64 (14) : 4995 - 5003